Style | Citing Format |
---|---|
MLA | Behranvand N, et al.. "Correction To: Chemotherapy: A Double‑Edged Sword in Cancer Treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/S00262-021-03013-3)." Cancer Immunology# Immunotherapy, vol. 71, no. 3, 2022, pp. 527-. |
APA | Behranvand N, Nasri F, Zolfaghari Emameh R, Khani P, Hosseini A, Garssen J, Falak R (2022). Correction To: Chemotherapy: A Double‑Edged Sword in Cancer Treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/S00262-021-03013-3). Cancer Immunology# Immunotherapy, 71(3), 527-. |
Chicago | Behranvand N, Nasri F, Zolfaghari Emameh R, Khani P, Hosseini A, Garssen J, Falak R. "Correction To: Chemotherapy: A Double‑Edged Sword in Cancer Treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/S00262-021-03013-3)." Cancer Immunology# Immunotherapy 71, no. 3 (2022): 527-. |
Harvard | Behranvand N et al. (2022) 'Correction To: Chemotherapy: A Double‑Edged Sword in Cancer Treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/S00262-021-03013-3)', Cancer Immunology# Immunotherapy, 71(3), pp. 527-. |
Vancouver | Behranvand N, Nasri F, Zolfaghari Emameh R, Khani P, Hosseini A, Garssen J, et al.. Correction To: Chemotherapy: A Double‑Edged Sword in Cancer Treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/S00262-021-03013-3). Cancer Immunology# Immunotherapy. 2022;71(3):527-. |
BibTex | @article{ author = {Behranvand N and Nasri F and Zolfaghari Emameh R and Khani P and Hosseini A and Garssen J and Falak R}, title = {Correction To: Chemotherapy: A Double‑Edged Sword in Cancer Treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/S00262-021-03013-3)}, journal = {Cancer Immunology# Immunotherapy}, volume = {71}, number = {3}, pages = {527-}, year = {2022} } |
RIS | TY - JOUR AU - Behranvand N AU - Nasri F AU - Zolfaghari Emameh R AU - Khani P AU - Hosseini A AU - Garssen J AU - Falak R TI - Correction To: Chemotherapy: A Double‑Edged Sword in Cancer Treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/S00262-021-03013-3) JO - Cancer Immunology# Immunotherapy VL - 71 IS - 3 SP - 527 EP - PY - 2022 ER - |